NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications

Experimental Hematology

Volumn 27, Issue 7, 1999, Pages 1168-1175

  Arima, Naomichi ^a   Matsushita, Kakushi ^a   Obata, Hachiro ^a   Ohtsubo, Hideo ^a   Fujiwara, Hiroshi ^a   Arimura, Kosei ^a   Kukita, Toshimasa ^a   Suruga, Yukio ^a   Wakamatsu, Shinichi ^a   Hidaka, Shiroh ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; C rel; KBF1; NF B

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TAX PROTEIN; ISOPROTEIN; MESSENGER RNA; NFKB1 PROTEIN, HUMAN; ONCOPROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TUMOR PROTEIN;

ACUTE LEUKEMIA; ARTICLE; CHRONIC LEUKEMIA; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; ACUTE DISEASE; AGED; BIOSYNTHESIS; CANCER STEM CELL; CELL CULTURE; CHRONIC DISEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KINETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REGULATOR GENE; T CELL LYMPHOMA; TRANSACTIVATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; GENES, PX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; KINETICS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0032586901     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00053-3     Document Type: Article

References (75)

1. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus (ATLV) from cell lines of adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 79:1982;2031.
2. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T cell leukemia virus. complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA Proc Natl Acad Sci. USA. 80:1983;3618.
3. Seiki M., Eddy R., Shows T.B., Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature. 309:1984;640.
4. Cross S.L., Feinberg M.B., Wolf J.B., Holbrook N.J., Wong-Staal F., Leonard W.J. Regulation of the human interleukin-2 receptor α chain promoter. activation of a non-functional promoter by the transactivator gene of HTLV-I Cell. 49:1987;47.
5. Fujii M., Sassone-Corsi P., Verma I.M. c-fos promoter trans-activation by the Tax-1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA. 85:1988;8526.
6. Inoue J.-M., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin-2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J. 5:1986;2883.
7. Maruyama M., Shibuya H., Harada H., Hatakeyama M., Seiki M., Fujita T., Inoue J., Yoshida M., Taniguchi T. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I encoded p40x and T3/Ti complex triggering. Cell. 48:1987;343.
8. Siekevitz M., Feinberg M.B., Holbrook N., Wong-Staal F., Greene W.C. Activation of interleukin-2 and interleukin-2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T cell leukemia virus, type I. Proc Natl Acad Sci USA. 84:1987;5389.
9. Wano Y., Feinberg M., Hosking J.B., Bogerd H., Greene W.C. Stable expression of the Tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth. Proc Natl Acad Sci USA. 85:1988;9733.
10. Smith M.R., Greene W.C. Molecular biology and the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J Clin Invest. 87:1991;761.
11. Ballard D.W., Bohenlein E., Lowenthal J.W., Wano Y., Franza B.R., Greene W.C. HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor-α gene. Science. 241:1988;1652.
12. Bohnlein E., Ballard D.W., Bogerd H., Peffer N.J., Lowenthal J.W., Greene W.C. Induction of interleukin-2 receptor-α gene expression is regulated by post-translational activation of κB specific DNA binding proteins. J Biol Chem. 264:1989;8475.
13. Bohnlein E., Lowenthal J.W., Siekevitz M., Ballard D.W., Franza B.R., Greene W.C. The same inducible nuclear protein(s) regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell. 53:1988;827.
14. Bours V., Villalobos J., Burd P.R., Kelly K., Siebenlist U. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature. 348:1990;76.
15. Ghosh S., Gifford A.M., Riviere R., Tempst P., Nolan G.P., Baltimore D. Cloning of the p50 DNA binding subunit of NF-kappa B. homology to rel and dorsal Cell. 62:1990;1019.
16. Hanly S.M., Rimsky L.T., Malin M.H., Kim J.H., Hauber J.H., DucDodon M., Le S.-Y.J., Maizel V., Cullen B.R., Greene W.C. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev. 3:1989;1534.
17. Kieran M., Blank V., Logeat F., Vandekerckhove J., Lottspeich F., Le Bail O., Urban M.B., Kourilsky P., Beuerle P.A., Israel A. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1990;1007.
18. Leung K., Nabel G. HTLV-I transactivator induces interleukin-2 receptor expression through and NF-κB-like factor. Nature. 333:1988;776.
19. Meyer R., Hatada E.N., Hohmann H.P., Haiker M., Bartsch C., Rothlisberger R., Lahm H.W., Schlaeger E.J., van Loon A.P.G.M., Scheidereit C. Cloning of the DNA binding subunit of human nuclear factor κB. the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha Proc Natl Acad Sci USA. 88:1991;966.
20. Molitor J.A., Walker W.H., Dorre S., Ballard D.W., Greene W.C. NF-κB. a family of inducible and differentially expressed enhancer-binding proteins in human T cells Proc Natl Acad Sci USA. 87:1990;10028.
21. Nolan G., Ghosh S., Liou H.C., Tempst P., Baltimore D. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel related polypeptide. Cell. 64:1991;961.
22. Ruben S., Dillon P., Schreck R., Henkel T., Chen C.H., Maher M., Baeuerle P., Rosen C.A. Isolation of a rel-related human cDNA that potentially enclodes the 65 kD subunit of NF-κB. Science. 251:1991;1490.
23. Ruben S., Poteat H., Han T.H., Kawakami K., Roeder R., Haseltine W., Rosen C.A. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I Tax gene product. Science. 241:1988;89.
24. Smith MR, Greene WC (1990) Identification of HTLV-I Tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875.
25. Shimoyama M., for members of the Lymphoma Study Group Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol. 79:1988;428.
26. Takatsuki K., Yamaguchi K., Kawano F., Hattori T., Nishimura H., Tsuda H., Sanada I., Nakada K., Itai Y. Clinical diversity in adult T-cell leukemia lymphoma. Cancer Res. 45:1991;4644.
27. Shimoyama M. Adult T-cell leukemia-lymphoma and its clinical subtypes from the viewpoints of viral etiology. Vogt P.K. Current topics in microbiology and immunology, Vol 115. 1985;113 Springer, Berlin.
28. Kawano F., Yamaguchi K., Nishimura H., Tsuda H., Takatsuki K. Variation in the clincial courses of adult T-cell leukemia. Cancer. 55:1985;851.
29. Arima N., Hidaka S., Fujiwara H., Matsushita K., Ohtsubo H., Arimura K., Kukita T., Fukumori J., Tanaka H. Relation of autonomous and interleukin-2 responsive growth of leukemic cells to survival in adult T-cell leukemia. Blood. 87:1996;2900.
30. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia. clincial and hematologic features of 16 cases Blood. 50:1977;48.
31. + T cell prolymphocytic leukemia cells mediated by NF-κB induction and IL-2 receptor α expression. Leukemia Res. 22:1998;265.
32. Stein B., Rhamsdorf H.F., Steffen A., Litfin M., Herrlich P. UVinduced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type l, collagenase, c-fos, and metallothionein. Mol Cell Biol. 9:1989;5169.
33. Maniatis T., Fritsch E.F., Sambrook J. Molecular cloning. a laboratory manual:1982;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
34. Ballard D.W., Bohnlein E., Hoffman J., Bogerd H., Dixon E., Franza B.R., Greene W.C. Activation of the interleukin-2 receptor alpha gene. regulatory role for DNA-protein interactions flanking the kappa B enhancer New Biologist. 1:1989;83.
35. Wu C., Wilson S., Walker B., David L., Paisley T., Zimarino B., Ueda H. Purification and properties of Drosophila heat shock activator protein. Science. 236:1987;1247.
36. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294.
37. Feinberg A.P., Vogelstein A. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 132:1983;6.
38. Kieran M., Blank V., Logeat F., Vandekerckhove J., Lottspeich F., Le Bail O., Urban M.B., Kourilsky P., Baeuerle P.A., Israel A. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1990;1007.
39. Ballard D.W., Walker W.H., Dorre S., Sista P., Molitor J.A., Dixon E.P., Peffer N.J., Hannink M., Greene W.C. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell. 63:1990;803.
40. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene. interspecies homology of sequences in the introns Proc Natl Acad Sci USA. 82:1985;6133.
41. Arima N., Molitor J.A., Smith M.R., Kim J.H., Daitoku Y., Greene W.C. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of κB enhancer-binding proteins. evidence for a pretranslational component of regulation J Virol. 65:1991;6892.
42. Seiki M., Hikikoshi A. Expression of the pX gene of HTLV-I. general splicing mechanim in the HTLV family Science. 228:1985;1532.
43. Arima N., Daitoku Y., Ohgaki S., Fukumori J., Tanaka H., Yamamoto Y., Fujimoto K., Onoue K. Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia. Blood. 68:1986;779.
44. Arima N., Daitoku Y., Yamamoto Y., Fujimoto K., Ohgaki S., Kojima K., Fukumori J., Matsushita K., Tanaka H., Onoue K. Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells. J Immunol. 138:1987;3069.
45. Inoue J., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin-2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J. 5:1986;2883.
46. Siekevitz M., Feinberg M.B., Holbrook N., Wong-Staal F., Greene W.C. Activation of interleukin-2 and interleukin -2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T cell leukemia virus, type I. Proc Natl Acad Sci USA. 84:1987;5389.
47. Wano Y., Hattori T., Matsuoka M., Takatsuki K., Chua A.O., Gubler U., Greene W.C. Interleukin 1 gene expression in adult T cell leukemia. J Clin Invest. 80:1987;911.
48. Honda S., Yamaguchi K., Miyake Y., Hayashi N., Adachi N., Kinoshita K., Ikehara O., Kimura S., Kinoshita T., Shimotohno K., Shimoyama M., Abe K. Production of parathyroid hormone-related protein in adult T-cell leukemia cells. Jpn J Cancer Res. 79:1988;1264.
49. Yano A., Yasukawa M., Yanagisawa K., Hasegawa H., Hato T., Minamoto Y., Kohno H., Kondo T., Fujita S., Kobayashi Y. Adult T cell leukemia associated with eosinophilia. analysis of eosinophil-stimulating factors produced by leukemic cells Acta Haematol. 88:1992;207.
50. Mori N., Shirakawa F., Murakami S., Oda S., Eto S. Inhibitory effect of interleukin 4 on production of interleukin 6 by adult T-cell leukemia cells. Cancer Res. 53:1993;4643.
51. Bargou R.C., Emmerich F., Krappmann D., Bommert K., Yapara M.Y., Arnold W., Royer H.D., Grinstein E., Greiner A., Scheidereit C., Dorken B. Constitutive nuclear factor-κB - Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 100:1997;2961.
52. Knecht H., McQuain C., Martin J., Rothenberger S., Drexler H.G., Berger C., Bachmann E., Kittler E.L.W., Odermatt B.F., Quesenberry P.J. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene. 13:1996;947.
53. Baeuerle P., Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell. 53:1988;211.
54. Baeuerle P., Baltimore D. I-kappa B. a specific inhibitor of the NF-kappa B transcription factor Science. 242:1988;540.
55. Bauerle P., Baltimore D. A 65-kD subunit of active NF-kappa B is required for inhibition of NF-kappa B by I-kappa B. Genes Dev. 3:1989;1689.
56. Ghosh S., Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I-kappa B. Nature. 344:1990;678.
57. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540.
58. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkB kinase that activates transcription factor NF-κB. Nature. 388:1997;548.
59. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J.W., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2. cytokine-activated IkB kinases essential for NF-κB activation Science. 278:1997;860.
60. Baeuerle P.A. Pro-inflammatory signaling. last pieces in the NF-κB puzzle? Curr Biol. 8:1998;R19.
61. Gerondakis S., Grumont R., Rourke I., Grossmann M. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr Opin Immunol. 10:1998;353.
62. Hirai H., Fujisawa J., Suzuki T., Ueda K., Muramatsu M., Tsuboi A., Arai N., Yoshida M. Transcriptional activator Tax of HTLV-I binds to the NF-kappa B precursor p105. Oncogene. 7:1992;1737.
63. Hirai H., Suzuki T., Fujisawa J., Inoue J., Yoshida M. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc Natl Acad Sci USA. 91:1994;3584.
64. Kanno T., Brown K., Franzoso G., Siebenlist U. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B. Mol Cell Biol. 14:1994;6443.
65. Lacoste J., Petropoulos L., Pepin N., Hiscott J. Constitutive phosphorylation and turnover of I kappa B alpha in human T-cell leukemia virus type I-infected and Tax-expressing T cells. J Viol. 69:1995;564.
66. Geleziunas R., Ferrell S., Lin X., Mu Y., Cunningham E.T., Grant M. Jr., Connelly M.A., Hambor J.E., Marcu K.B., Greene W.C. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases. Mol Cell Biol. 18:1998;5157.
67. Chu Z.-L., DiDonato J.A., Hawiger J., Ballard D.W. The Tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ J Biol Chem. 273:1998;15891.
68. Uhlik M., Good L., Xiao G., Harhaj E.W., Zandi E., Karin M., Sun S.-C. NF-κB - inducing kinase and IkB kinase participate in human T-cell leukemia virus I Tax-mediated NF-κB activation. J Biol Chem. 273:1998;21132.
69. Muroz E., Courtois G., Veschambre P., Jalinot P., Israel A. Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol. 68:1994;8035.
70. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704.
71. Sherr C.J., Roberts J.M. Inhibitions of mammanlian G1 cyclindependent kinases. Genes Dev. 9:1995;1149.
72. Hatta Y., Hirama T., Miller C.W., Yamada Y., Tomonaga M., Koeffler H.P. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood. 85:1995;2699.
73. Sakashita A., Hattori T., Miller C.W., Suzushima H., Asou N., Takatsuki K., Koeffler H.P. Mutations of the p53 gene in adult T-cell leukemia. Blood. 79:1992;477.
74. Suzuki T., Kitao S., Matsushime H., Yoshida M. HTLV-I Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15:1996;1607.
75. Pise-Masison C.A., Choi K.-S., Radonovich M., Dittmer J., Kim S.-J., Brady J.N. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type I Tax protein. J Virol. 72:1998;1165.